Cargando…
Models of SIV rebound after treatment interruption that involve multiple reactivation events
In order to assess the efficacy of novel HIV-1 treatments leading to a functional cure, the time to viral rebound is frequently used as a surrogate endpoint. The longer the time to viral rebound, the more efficacious the therapy. In support of such an approach, mathematical models serve as a connect...
Autores principales: | van Dorp, Christiaan H., Conway, Jessica M., Barouch, Dan H., Whitney, James B., Perelson, Alan S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7529301/ https://www.ncbi.nlm.nih.gov/pubmed/33001979 http://dx.doi.org/10.1371/journal.pcbi.1008241 |
Ejemplares similares
-
Genetically-barcoded SIV facilitates enumeration of rebound variants and estimation of reactivation rates in nonhuman primates following interruption of suppressive antiretroviral therapy
por: Fennessey, Christine M., et al.
Publicado: (2017) -
Peripheral blood biomarkers predict viral rebound following antiretroviral therapy discontinuation in SIV-infected, early ART-treated rhesus macaques
por: Aid, Malika, et al.
Publicado: (2023) -
Origin of rebound virus in chronically SIV-infected Rhesus monkeys following treatment discontinuation
por: Liu, Po-Ting, et al.
Publicado: (2020) -
Predictions of time to HIV viral rebound following ART suspension that incorporate personal biomarkers
por: Conway, Jessica M., et al.
Publicado: (2019) -
Unified model of short- and long-term HIV viral rebound for clinical trial planning
por: Conway, Jessica M., et al.
Publicado: (2021)